09:48 AM EST - Avicanna Inc. : Announced today that the Company has expanded its research collaboration with Dr. Christine Allen's Research Group in the Leslie Dan Faculty of Pharmacy at the University of Toronto, to include the expedited development of a cannabinoid-based treatment for lung inflammation associated with COVID-19. Avicanna Inc.
shares T.AVCN are trading unchanged at $1.55.
